Literature DB >> 11917276

The evolution and application of toxicity criteria.

Andy Trotti1.   

Abstract

The assessment and reporting of toxicity plays a central role in oncology. The foundation of toxicity reporting is the toxicity criteria system. Multiple systems have been developed and have evolved substantially since first introduced more than 20 years ago. The wide adoption of a standardized criteria system can facilitate comparison between institutions and clinical trials. The Common Toxicity Criteria (CTC) system was revised and expanded substantially in 1997 and now includes acute radiation criteria as part of multimodality grading. In contrast to the progress made in standardizing acute effects, the current use of multiple late effects grading systems by different groups hinders comparability of clinical trials, impedes the development of toxicity interventions, and encumbers the proper recognition and reporting of late effects. Just as the revised CTC has provided a new common standard for the grading of acute effects, a similar effort is needed in the late effects area. The creation of a unified late effects system is under active development. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 11917276     DOI: 10.1053/srao.2002.31353

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  3 in total

1.  Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events.

Authors:  Tamara P Miller; Brian T Fisher; Kelly D Getz; Leah Sack; Hanieh Razzaghi; Alix E Seif; Rochelle Bagatell; Peter C Adamson; Richard Aplenc
Journal:  Pediatr Blood Cancer       Date:  2019-04-09       Impact factor: 3.167

2.  Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvis.

Authors:  Konstantinos H Katsanos; Evangelos Briasoulis; Pericles Tsekeris; Anna Batistatou; Maria Bai; Christos Tolis; Antonio Capizzello; Ioannis Panelos; Vasileios Karavasilis; Dimitrios Christodoulou; Epameinondas V Tsianos
Journal:  J Exp Clin Cancer Res       Date:  2010-06-10

3.  A modified Inflammatory Bowel Disease questionnaire and the Vaizey Incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy.

Authors:  F A Olopade; A Norman; P Blake; D P Dearnaley; K J Harrington; V Khoo; D Tait; C Hackett; H J N Andreyev
Journal:  Br J Cancer       Date:  2005-05-09       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.